Related Experiment Video
Updated: Oct 29, 2025

11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.4K
Pembrolizumab use in bladder cancer: a tale of two trials
1GU Medical Oncology, Inova Schar Cancer Institute, Fairfax, VA, USA. Jeanny.Aragon-Ching@inova.org.
Nature Reviews. Urology
|July 7, 2021
Abstract
No abstract available in PubMed .

